Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Director departure
Blue Water Biotech, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
10/10/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
10/10/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Employment Agreement, between the Company and Dr. Neil Campbell",
"Employment Agreement, between the Company and Bruce Harmon",
"Form of Indemnification Agreement",
"General Release of Claims",
"Blue Water Biotech Appoints Dr. Neil J. Campbell as President and CEO and Bruce Harmon as CFO"
10/03/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ...
Docs: "CERTIFICATE OF DESIGNATIONS OF SERIES A PREFERRED STOCK",
"AMENDMENT TO"
08/22/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/15/2023 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
08/10/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Blue Water Biotech and Copay Consultants Collaborate to Build Copay Assistance Programs for Blue Water’ s Commercial Products"
08/03/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ...
Docs: "FORM OF INDUCEMENT PIO",
"FORM OF LETTER AGREEMENT",
"Blue Water Biotech Announces Closing of Warrant Exercise and Issuance of New Warrants in A Private Placement For $2.7 Million Gross Proceeds"
08/01/2023 8-K Quarterly results
07/31/2023 8-K Quarterly results
07/25/2023 8-K Quarterly results
07/21/2023 8-K Quarterly results
07/17/2023 8-K Quarterly results
07/11/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Blue Water Biotech Teams with Advantage Point Solutions to Provide Healthcare Payer Coverage Support"
07/06/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Blue Water Biotech Secures License from Ohio State Board of Pharmacy to Operate as Pharmaceutical Wholesaler for its FDA Approved Products"
07/06/2023 8-K Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits  Interactive Data
Docs: "Letter from Mayer Hoffman McCann P.C."
07/06/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Blue Water Biotech Teams with BFW Advertising to Market and Advertise Commercial Product Portfolio"
06/29/2023 SC 13D Cincinnati Cornerstone Investors BWV I, LLC reports a 0% stake in Blue Water Biotech, Inc.
06/06/2023 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "THIRD AMENDED AND RESTATED BYLAWS OF BLUE WATER BIOTECH, INC"
06/01/2023 4 Jeremic Vuk (Director) has filed a Form 4 on Blue Water Biotech, Inc.
Txns: Granted 6,360 shares @ $0
06/01/2023 4 Ramdeen Timothy R. (Director) has filed a Form 4 on Blue Water Biotech, Inc.
Txns: Granted 6,360 shares @ $0
06/01/2023 4 Tarsh Simon (Director) has filed a Form 4 on Blue Water Biotech, Inc.
Txns: Granted 6,360 shares @ $0
06/01/2023 4 SAPIRSTEIN JAMES (Director) has filed a Form 4 on Blue Water Biotech, Inc.
Txns: Granted 6,360 shares @ $0
05/15/2023 8-K Investor presentation
Docs: "PRESENTATION, DATED MAY 2023"
05/12/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/11/2023 4 Hernandez Joseph (CEO) has filed a Form 4 on Blue Water Biotech, Inc.
Txns: Granted 150,000 shares @ $0
05/11/2023 4 Garfield Jon (CFO) has filed a Form 4 on Blue Water Biotech, Inc.
Txns: Granted 100,000 shares @ $0
05/11/2023 4 Henderson Erin (Chief Business Officer) has filed a Form 4 on Blue Water Biotech, Inc.
Txns: Granted 150,000 shares @ $0
05/10/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Blue Water Biotech to Present Corporate Overview and ENTADFI Launch Plan at the JMP Securities Life Sciences Conference in"
05/05/2023 EFFECT Form EFFECT - Notice of Effectiveness:
04/28/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
04/26/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/24/2023 8-K Quarterly results
04/20/2023 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy